SCHEMBL2472113

SCHEMBL2472113

O=C(O)N(CCCN1CCCC1)c1cccc(Cn2nc(-c3ccc(F)c(F)c3)ccc2=O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 11/20 0.44
USP2 O75604 2/20 0.42
TSHR P16473 2/20 0.42
CTSS P25774 1/20 0.42
ALOX15 P16050 2/20 0.42
MEN1 O00255 1/20 0.42
CYP3A4 P08684 1/20 0.42
GAA P10253 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
HDAC1 Q13547 1/20 0.40
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
POLB P06746 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2466580 0.95 MET (0.44) METUSP2TSHRCTSSMEN1
SCHEMBL2469433 0.94 MET (0.44) METUSP2TSHRMEN1KMT2A
SCHEMBL2470373 0.93 MET (0.43) METUSP2TSHRMEN1KMT2A
SCHEMBL2470606 0.93 MET (0.53) METUSP2TSHRCYP3A4MAPT
SCHEMBL2466209 0.93 MET (0.46) METUSP2TSHRCTSSALOX15
SCHEMBL2469731 0.90 MET (0.54) METTSHRALOX15MEN1CYP3A4
SCHEMBL2466028 0.89 MET (0.45) METUSP2TSHRMEN1KMT2A
SCHEMBL2464470 0.88 MET (0.43) METUSP2TSHRMEN1KMT2A
SCHEMBL2469403 0.88 MET (0.51) METUSP2TSHRMEN1CYP3A4
SCHEMBL2467270 0.86 MET (0.53) METMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173653-B2 Pyridiazinone derivatives for the treatment of tumours MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2012-05-08 US claimed
EP-1960370-B1 PYRIDIAZINONE DERIVATIVES FOR TUMOUR TREATMENT MERCK PATENT GMBH (DE) 2011-10-05 EP claimed